Animal Pharm is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Operations

Set Alert for Operations

BV Science boosts European presence with new distribution site

US feed additives firm BV Science has increased its presence in Europe after opening a new distribution center in Budapest, Hungary.

Operations

Covetrus posts flat Q2, anticipates 'low single-digit' growth for 2019

Covetrus has posted sales of around $1 billion for the second quarter of 2019, representing a flat year-on-year comparison.

Financial Results Operations

Boehringer takes next step in China strategy with opening of animal health hub

Boehringer Ingelheim has opened a new animal health management center in Shanghai, China.

Boehringer Ingelheim Animal Health Operations

Elanco Q2 sales bugged by currency exchange, no mention of Bayer deal

Elanco's second-quarter revenues have been impacted by foreign currency exchange rates and the firm has scaled back its full-year forecast due to African swine fever (ASF).

Elanco Financial Results

ImmuCell Q2 hit by order backlogs, net loss still declining

ImmuCell has seen its sales drop in Q2 2019, after previously recording its "best quarter ever". 

Financial Results Operations

US firm launches veterinary diagnostics subsidiary, appoints CEO

Texas-based Volition has established Volition Veterinary Diagnostics (VVG) a veterinary subsidiary to its human life sciences division.

Diagnostics Cancer

PetIQ continues prosperous year into second quarter

US companion animal medication provider PetIQ has again recorded 29% quarterly sales growth. 

Financial Results Operations

KindredBio plans parvovirus mAb launch in next two years, claims 'blockbuster' pipeline potential

Kindred Biosciences chief executive Richard Chin has said the firm is aiming to launch its monoclonal antibody candidate against canine parvovirus by the end of 2020 or early 2021. 

Kindred Biosciences R&D

First signs of Nexvet pipeline come to light with new Zoetis cat mAb

Zoetis expects to gain approval for a new monoclonal antibody (mAb) to control pain associated with osteoarthritis in cats in 2021.

Feline Zoetis

Bioceltix: Stem cell pathway made easier by first European commercialization

Polish start-up Bioceltix is seeking EU Good Manufacturing Practice certification to produce its mesenchymal stromal cell product candidates by the end of 2019.

Companion Animals Operations

Intervacc takes one step closer to European submission for horse vaccine

Swedish business Intervacc has finalized production of its vaccine for equine strangles on a commercial scale.

Vaccines Equine

Vetio boosts manufacturing and development scale with Montreal expansion

St Louis, Missouri-headquartered Vetio Animal Health has completed the expansion of its Montreal plant expansion.

Operations
Advertisement
UsernamePublicRestriction

Register